Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

ProRx LLC recalls Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL
Company
ProRx LLC
Where it was sold

Nationwide in the USA

Nationwide

Units affected
37 vials
About this recall
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01